Pharma-Bio Serv, Inc.

Company type and structure

• Delaware corporation organized on January 14, 2004.
• Headquarters in Puerto Rico; operations in Puerto Rico, the United States, Europe, and Brazil.
• Three reportable operating segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, and Europe technical compliance consulting.

Core business

• Regulatory affairs, quality, compliance, and technology transfer consulting firm.
• Focus areas: regulatory compliance, validation, technology transfer, engineering, project management, and process support.
• Serves pharmaceutical, chemical, biotechnology, medical devices, cosmetic, and food industries, and allied products companies.

Services and delivery model

• Revenue primarily from time-and-materials contracts (approximately 99%), with a minority of fixed-fee or “not to exceed” contracts (about 1%).
• Time-and-materials revenue depends on the number of consultants and hours billed; fixed-price contracts require accurate cost estimation and monitoring.

Market and growth strategy

• Target markets: Puerto Rico, United States, Europe, and Brazil.
• Growth drivers include expanding technical services, quality assurance, regulatory compliance, technology transfer, validation, engineering, and manufacturing; increasing market presence in the U.S., Europe, Brazil, and other emerging markets; and growth through internal development and acquisitions.
• Marketing emphasizes major accounts, using project managers and senior management relationships, and ongoing participation in industry events.

Customers

• Served approximately 70 customers in the year ended October 31, 2025.
• Revenue concentration: three customers accounted for 43.5% of total revenue in 2025 (down from 44.2% in 2024). In both 2025 and 2024, those top customers each represented 10% or more of revenue.

Workforce

• Approximately 55 employees plus 20 independent contractors (all full-time staff).
• Human capital is a critical asset.
• No employees are represented by a labor union.

Intellectual property

• No proprietary software or products.
• Protection relies on non-disclosure agreements with employees and confidentiality agreements with clients.

Leadership

• Victor Sanchez, 55 — Chief Executive Officer, President, and President of European Operations (CEO and President since 2015; President of European Operations since 2011).
• Pedro J. Lasanta, 66 — Chief Financial Officer, Vice President – Finance and Administration, and Secretary (since 2007).

Physical offices

• As of January 1, 2026, operates as a remote company with one office in Madrid, Spain (month-to-month lease, approximately $500 per month).
• Previously maintained administrative offices in Dorado, Puerto Rico; those leases have been terminated.